Phosphorylated tau exhibits antimicrobial activity capable of neutralizing herpes simplex virus 1 infectivity in human neurons.
Level 5 - mechanism / opinion, no new human data
Bench/in vitro mechanistic research with no direct clinical human trial data.
PubMed 41408481 · doi:10.1038/s41593-025-02157-0
What was done
In vitro experiments examined the response of human neuronal tau to viral challenge. Investigators tested whether viral infection triggers tau hyperphosphorylation and evaluated whether phosphorylated tau directly binds to herpes simplex virus 1 (HSV-1) capsids to neutralize viral infectivity.
What was found
Tau was hyperphosphorylated in neurons upon viral infection and neutralized HSV-1 infectivity through direct capsid binding. The abstract reports qualitative mechanistic observations without numerical metrics, effect sizes, or confidence intervals.
Why it matters
These findings suggest that tau hyperphosphorylation and aggregation may originate as an innate antimicrobial defense mechanism. Alongside amyloid-beta, this supports the model that classic Alzheimer's neuropathology may represent an orchestrated immune response to brain infection.
Limits
The abstract provides no sample sizes, quantification of neutralization potency, or specific experimental counts. The work is strictly preclinical and in vitro, leaving in vivo relevance, human clinical applicability, and pathogen specificity unmeasured.
Cited by
- supports Beta-amyloid, phosphorylated tau, and alpha-synuclein are antimicrobial peptides.